1 | 1 | | 1 of 1 |
---|
2 | 2 | | HOUSE DOCKET, NO. 3572 FILED ON: 1/17/2025 |
---|
3 | 3 | | HOUSE . . . . . . . . . . . . . . . No. 2535 |
---|
4 | 4 | | The Commonwealth of Massachusetts |
---|
5 | 5 | | _________________ |
---|
6 | 6 | | PRESENTED BY: |
---|
7 | 7 | | Greg Schwartz and Kate Donaghue |
---|
8 | 8 | | _________________ |
---|
9 | 9 | | To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General |
---|
10 | 10 | | Court assembled: |
---|
11 | 11 | | The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill: |
---|
12 | 12 | | An Act establishing a Naloxone Purchase Trust fund. |
---|
13 | 13 | | _______________ |
---|
14 | 14 | | PETITION OF: |
---|
15 | 15 | | NAME:DISTRICT/ADDRESS :DATE ADDED:Greg Schwartz12th Middlesex1/17/2025Kate Donaghue19th Worcester1/21/2025Christine P. Barber34th Middlesex3/4/2025James B. EldridgeMiddlesex and Worcester2/7/2025David Henry Argosky LeBoeuf17th Worcester2/10/2025Lindsay N. Sabadosa1st Hampshire2/24/2025Margaret R. Scarsdale1st Middlesex3/3/2025 1 of 3 |
---|
16 | 16 | | HOUSE DOCKET, NO. 3572 FILED ON: 1/17/2025 |
---|
17 | 17 | | HOUSE . . . . . . . . . . . . . . . No. 2535 |
---|
18 | 18 | | By Representatives Schwartz of Newton and Donaghue of Westborough, a petition |
---|
19 | 19 | | (accompanied by bill, House, No. 2535) of Greg Schwartz, Kate Donaghue and others for |
---|
20 | 20 | | legislation to establish a universal purchase system for opioid antagonist distribution in the |
---|
21 | 21 | | Commonwealth. Public Health. |
---|
22 | 22 | | The Commonwealth of Massachusetts |
---|
23 | 23 | | _______________ |
---|
24 | 24 | | In the One Hundred and Ninety-Fourth General Court |
---|
25 | 25 | | (2025-2026) |
---|
26 | 26 | | _______________ |
---|
27 | 27 | | An Act establishing a Naloxone Purchase Trust fund. |
---|
28 | 28 | | Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority |
---|
29 | 29 | | of the same, as follows: |
---|
30 | 30 | | 1 SECTION X. Chapter 111 of the General Laws is hereby amended by inserting the |
---|
31 | 31 | | 2following section:- |
---|
32 | 32 | | 3 Section XX. |
---|
33 | 33 | | 4 (a) As used in this section the following words shall, unless the context clearly requires |
---|
34 | 34 | | 5otherwise, have the following meanings:- |
---|
35 | 35 | | 6 “Estimated cost'', a projection of funds needed during a fiscal year for the purchase, |
---|
36 | 36 | | 7storage and distribution of opioid antagonists. |
---|
37 | 37 | | 8 ''Opioid antagonist'', naloxone or any other drug approved by the federal Food and Drug |
---|
38 | 38 | | 9Administration as a competitive narcotic antagonist used in the reversal of overdoses caused by |
---|
39 | 39 | | 10opioids. 2 of 3 |
---|
40 | 40 | | 11 “Opioid antagonist distribution”, the distribution of opioid antagonists to healthcare |
---|
41 | 41 | | 12facilities including but not limited to: |
---|
42 | 42 | | 13 (i)acute care hospitals; |
---|
43 | 43 | | 14 (ii)emergency departments; |
---|
44 | 44 | | 15 (iii)substance use disorder treatment facilities; and |
---|
45 | 45 | | 16 (iv)community health centers; |
---|
46 | 46 | | 17 provided that, opioid antagonists shall be offered to a patient who has (i) a history of |
---|
47 | 47 | | 18using opioids; (ii) been diagnosed with opioid use disorder; or (iii) experienced an opioid-related |
---|
48 | 48 | | 19overdose. |
---|
49 | 49 | | 20 “Substance use disorder treatment facilities”, a facility licensed or approved by the |
---|
50 | 50 | | 21department or the department of mental health to offer treatment for substance use disorder, |
---|
51 | 51 | | 22including, but not limited to: (i) withdrawal management services; (ii) clinical stabilization |
---|
52 | 52 | | 23services; (iii) transitional support services; (iv) residential support services; (v) community |
---|
53 | 53 | | 24behavioral health center services; (vi) office-based opioid or addiction treatment services; or (vii) |
---|
54 | 54 | | 25inpatient or outpatient substance use disorder services. |
---|
55 | 55 | | 26 (b) There shall be established in the commonwealth a separate trust fund to be known as |
---|
56 | 56 | | 27the Naloxone Purchase Trust Fund to support a universal purchase system for opioid antagonist |
---|
57 | 57 | | 28distribution in the commonwealth. The fund shall be expended to cover the costs of opioid |
---|
58 | 58 | | 29antagonist distribution. The fund shall consist of all monies transferred from the executive office |
---|
59 | 59 | | 30of health and human services pursuant to section 66 of chapter 118E, all money received as |
---|
60 | 60 | | 31voluntary contributions to the fund, including but not limited to contributions from third party 3 of 3 |
---|
61 | 61 | | 32payers or third party administrators, as defined in section 1 of chapter 12C and any interest |
---|
62 | 62 | | 33earnings on such monies. The fund shall be maintained by the commissioner of the department or |
---|
63 | 63 | | 34a designee. The monies shall be expended under the direction of the department, without prior |
---|
64 | 64 | | 35appropriation, solely to cover opioid antagonist distribution program costs; provided, however, |
---|
65 | 65 | | 36that the amount to be expended for storing and distributing opioid antagonists, if such costs are |
---|
66 | 66 | | 37not covered by federal contribution, shall not exceed 10 per cent of the total amount of the fund |
---|
67 | 67 | | 38expended for the purchase of naloxone needed for opioid agonist distribution in the |
---|
68 | 68 | | 39commonwealth. The department may incur expenses and the comptroller may certify for |
---|
69 | 69 | | 40payment amounts in anticipation of the most recent estimate of expected receipts, as certified by |
---|
70 | 70 | | 41the secretary of administration and finance; provided, however, that no expenditure shall be |
---|
71 | 71 | | 42made from the fund which shall cause the fund to be in deficit at the close of a fiscal year. Any |
---|
72 | 72 | | 43balance in the fund at the close of a fiscal year shall be available for expenditure in subsequent |
---|
73 | 73 | | 44fiscal years and shall not be transferred to any other fund or revert to the General Fund. The |
---|
74 | 74 | | 45commissioner of the department or a designee shall annually report the amount of funds |
---|
75 | 75 | | 46collected and any expenditures made from the fund to the clerks of the house of representatives |
---|
76 | 76 | | 47and senate to be forwarded on to the house and senate committees on ways and means, the house |
---|
77 | 77 | | 48and senate chairs of the joint committee on public health and the house and senate chairs of the |
---|
78 | 78 | | 49joint committee on health care financing. |
---|
79 | 79 | | 50 (c) The department may adopt rules and regulations as necessary to implement the |
---|
80 | 80 | | 51universal purchase and distribution system under this chapter and other applicable state and |
---|
81 | 81 | | 52federal laws. |
---|